930421960	930421960	CD	B-NP	O
|	|	NN	I-NP	O
FUOC	FUOC	NN	I-NP	O
|	|	NN	I-NP	O
48167720	48167720	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9559184	9559184	CD	B-NP	O
|	|	CC	I-NP	O
2/9/2002	2/9/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
atypical	atypical	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/9/2002	2/9/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/28/2002	10/28/2002	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
ZERBE	ZERBE	NN	B-NP	B-protein
,	,	,	O	O
ROLANDO	ROLANDO	NN	B-NP	O
529-74-03-4	529-74-03-4	CD	I-NP	O
Jer	Jer	NNP	I-NP	O
Boise	Boise	NNP	I-NP	O
Mi	Mi	NNP	I-NP	O
,	,	,	O	O
Illinois	Illinois	NNP	B-NP	O
40718	40718	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
7/29/02	7/29/02	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
PIGAT	PIGAT	NN	B-NP	B-protein
,	,	,	O	O
ZACHARY	ZACHARY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NN	B-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ASPIRIN	ASPIRIN	NNP	I-NP	I-protein
ENTERIC	ENTERIC	NNP	I-NP	I-protein
COATED	COATED	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
HCTZ	HCTZ	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
25	25	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
call	call	NN	B-NP	O
MD	MD	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/11/02	10/11/02	CD	B-NP	O
by	by	IN	B-PP	O
HODDE	HODDE	NNP	B-NP	O
,	,	,	O	O
JOAN	JOAN	NNP	B-NP	O
R	R	NNP	I-NP	O
FAUSTO	FAUSTO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NN	B-NP	O
IV	IV	CD	I-NP	O
10	10	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
51964008	51964008	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/11/02	10/11/02	CD	B-NP	O
by	by	IN	B-PP	O
GALLUPS	GALLUPS	NNP	B-NP	O
,	,	,	O	O
SHERMAN	SHERMAN	NNP	B-NP	O
DENNIS	DENNIS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
63529506	63529506	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/11/02	10/11/02	CD	B-NP	O
by	by	IN	B-PP	O
LUAGUE	LUAGUE	NN	B-NP	O
,	,	,	O	O
RAFAEL	RAFAEL	NN	B-NP	O
CARTER	CARTER	NN	I-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NN	B-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
12388972	12388972	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/11/02	10/11/02	CD	B-NP	O
by	by	IN	B-PP	O
HOEFFER	HOEFFER	NN	B-NP	O
,	,	,	O	O
CHRIS	CHRIS	NNP	B-NP	O
VITO	VITO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
38948535	38948535	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/11/02	10/11/02	CD	B-NP	O
by	by	IN	B-PP	O
HUBSCH	HUBSCH	NN	B-NP	O
,	,	,	O	O
BRADFORD	BRADFORD	NNP	B-NP	O
CORDELL	CORDELL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
37650967	37650967	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
MAALOX	MAALOX	NNP	B-NP	O
PLUS	PLUS	NNP	I-NP	O
EXTRA	EXTRA	NNP	I-NP	O
STRENGTH	STRENGTH	NNP	I-NP	O
15	15	CD	I-NP	O
milliliters	milliliter	NNS	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Indigestion	Indigestion	NNP	I-NP	O
VERAPAMIL	VERAPAMIL	NNP	I-NP	O
SUSTAINED	SUSTAINED	NNP	I-NP	O
RELEAS	RELEAS	NNP	I-NP	O
240	240	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
June	June	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
this	this	DT	B-NP	O
it	it	PRP	B-NP	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
usual	usual	JJ	I-NP	O
dose	dose	NN	I-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Avoid	Avoid	JJ	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/11/02	1/11/02	CD	B-NP	O
by	by	IN	B-PP	O
EKSTEIN	EKSTEIN	NNP	B-NP	O
,	,	,	O	O
CHADWICK	CHADWICK	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LOPRESSOR	LOPRESSOR	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
27945736	27945736	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
VERAPAMIL	VERAPAMIL	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
,	,	,	O	O
SUSTAINED-REL	SUSTAINED-REL	NNP	B-NP	O
&	&	CC	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
noted	note	VBN	B-NP	O
PREVACID	PREVACID	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LANSOPRAZOLE	LANSOPRAZOLE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
X	X	SYM	B-NP	O
1	1	CD	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
PCH	PCH	NN	B-NP	O
Potassium	Potassium	NN	I-NP	O
Chloride	Chloride	NN	I-NP	O
Policy	Policy	NN	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	JJ	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/29/02	7/29/02	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
following	follow	VBG	I-VP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
VITAMIN	VITAMIN	NN	I-NP	O
E	E	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
TOCOPHEROL-DL-ALPHA	TOCOPHEROL-DL-ALPHA	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
400	400	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Verhulst	Verhulst	NNP	I-NP	O
,	,	,	O	O
PMD	PMD	NNP	B-NP	O
1-2	1-2	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Penicillins	Penicillin	NNS	B-NP	B-protein
,	,	,	O	O
Compazine	Compazine	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
phenothiazines	phenothiazine	NNS	I-NP	O
-RRB-	-RRB-	VBP	B-VP	O
ADMIT	ADMIT	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
r/o	r/o	NN	B-NP	O
mi	mi	NNS	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
atypical	atypical	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
menorrhagia	menorrhagia	NN	I-NP	O
htn	htn	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Dobutamine-MIBI	Dobutamine-MIBI	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
48	48	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
w	w	NN	I-NP	O
PMHx	PMHx	NN	I-NP	O
HTN	HTN	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
one	one	CD	I-NP	O
day	day	NN	I-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
describes	describe	VBZ	B-VP	O
onset	onset	NN	B-NP	O
of	of	IN	B-PP	O
CP	CP	NN	B-NP	B-DNA
at	at	IN	B-PP	O
11am	11am	NN	B-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
while	while	IN	B-SBAR	O
walking	walk	VBG	B-VP	O
up	up	RP	B-PRT	O
3	3	CD	B-NP	O
flights	flight	NNS	I-NP	O
of	of	IN	B-PP	O
stairs	stair	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
became	become	VBD	B-VP	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
severe	severe	JJ	B-NP	O
headache	headache	NN	I-NP	O
and	and	CC	O	O
developed	develop	VBD	B-VP	O
tightness	tightness	NN	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
up	up	RP	B-PRT	O
her	her	PRP$	B-NP	O
neck	neck	NN	I-NP	O
and	and	CC	O	O
down	down	RB	B-ADVP	O
L	L	NN	B-NP	O
arm	arm	NN	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
burning	burn	VBG	B-VP	O
under	under	IN	B-PP	O
L	L	NN	B-NP	O
breast	breast	NN	I-NP	O
rad	rad	NN	I-NP	O
to	to	TO	B-VP	O
back	back	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
rested	rest	VBD	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
top	top	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
stairs	stair	NNS	I-NP	O
and	and	CC	I-NP	O
pain	pain	NN	I-NP	O
resided	reside	VBD	B-VP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
go	go	VB	I-VP	O
away	away	RB	B-ADVP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
returned	return	VBD	B-VP	O
3x	3x	NN	B-NP	O
during	during	IN	B-PP	O
day	day	NN	B-NP	O
sometimes	sometimes	RB	B-ADVP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
+	+	SYM	B-NP	O
nausea	nausea	NN	I-NP	O
not	not	RB	B-ADVP	O
always	always	RB	I-ADVP	O
asso	asso	RB	B-ADVP	O
with	with	IN	B-PP	O
pain	pain	NN	B-NP	O
and	and	CC	O	O
vomitting	vomitte	VBG	B-VP	B-protein
x	x	NN	B-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

Cold	Cold	NNP	B-NP	O
sweat	sweat	VBD	B-VP	O
early	early	RB	B-ADVP	O
in	in	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	B-NP	O
not	not	RB	I-NP	O
associated	associate	VBN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	I-NP	O
CP	CP	NN	I-NP	B-DNA
.	.	.	O	O

On	On	IN	B-PP	O
arriv	arriv	NN	B-NP	O
al	al	JJ	B-ADJP	O
to	to	TO	B-PP	O
ED	ED	VBN	B-NP	O
pt	pt	NN	I-NP	O
described	describe	VBN	B-VP	O
pain	pain	NN	B-NP	O
10/10	10/10	CD	I-NP	O
,	,	,	O	O
nitro	nitro	NN	B-NP	B-protein
x	x	SYM	O	I-protein
3	3	CD	B-NP	I-protein
1/10	1/10	CD	I-NP	I-protein
,	,	,	O	O
given	give	VBN	B-PP	O
MSO4	MSO4	NN	B-NP	B-protein
,	,	,	O	O
went	go	VBD	B-VP	O
away	away	RB	B-ADVP	O
sometime	sometime	RB	B-ADVP	O
after	after	IN	B-PP	O
that	that	DT	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
resent	resent	JJ	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
max	max	NN	B-NP	O
dose	dose	NN	I-NP	O
Verapamil	Verapamil	NNP	I-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
,	,	,	O	O
Atenolol	Atenolol	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/9/02	1/9/02	CD	B-NP	O
.	.	.	O	O

VS	VS	NN	B-NP	O
P	P	NN	I-NP	O
54	54	CD	I-NP	O
r18	r18	NN	I-NP	O
BP	BP	NN	I-NP	O
140s/80s	140s/80s	CD	B-NP	O
O2sat	O2sat	NN	I-NP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
in	in	IN	B-PP	O
NAD	NAD	NN	B-NP	O
,	,	,	O	O
skin	skin	NN	B-NP	O
warm	warm	NN	I-NP	O
and	and	CC	O	O
dry	dry	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
JVD	JVD	NNP	I-NP	O
,	,	,	O	O
CV	CV	NNP	B-NP	O
rrr	rrr	VBP	B-VP	O
no	no	DT	B-NP	O
m/r/g	m/r/g	NN	I-NP	O
,	,	,	O	O
lungs	lung	VBZ	B-VP	O
cta	cta	NN	B-NP	O
bilat	bilat	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Hospital	Hospital	NN	B-NP	O
course	course	NN	I-NP	O
by	by	IN	B-PP	O
problem	problem	NN	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CP	CP	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
with	with	IN	B-PP	O
story	story	NN	B-NP	O
unlikely	unlikely	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
cardiac	cardiac	JJ	B-NP	O
origin	origin	NN	I-NP	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
RF	RF	NN	B-NP	B-protein
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
in	in	IN	B-PP	O
HTN	HTN	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
sig	sig	NN	I-NP	O
fhx	fhx	NN	I-NP	O
.	.	.	O	O

Rule	Rule	NNP	B-NP	O
out	out	RP	B-PRT	O
by	by	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
.	.	.	O	O

CT	CT	NN	B-NP	O
chest	chest	NN	I-NP	O
in	in	IN	B-PP	O
ED	ED	JJ	B-NP	O
neg	neg	NN	I-NP	O
for	for	IN	B-PP	O
PE	PE	NN	B-NP	O
or	or	CC	I-NP	O
dissection	dissection	NN	I-NP	O
.	.	.	O	O

Was	Was	NNP	B-NP	O
kept	keep	VBD	B-VP	O
on	on	IN	B-PP	O
BBlock	BBlock	NNP	B-NP	O
after	after	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
bu	bu	NN	B-NP	O
t	t	NN	I-NP	O
c/o	c/o	NN	I-NP	O
feeling	feeling	NN	I-NP	O
heavy	heavy	NN	I-NP	O
and	and	CC	O	O
noted	note	VBD	B-VP	O
significant	significant	JJ	B-NP	O
Bradycardia	Bradycardia	NNP	I-NP	O
overnight	overnight	RB	B-ADVP	O
to	to	TO	B-PP	O
48-52	48-52	CD	B-NP	O
.	.	.	O	O

BBlock	BBlock	NN	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	B-ADVP	O
DC	DC	NN	B-NP	B-cell_type
'd	'd	MD	O	O
and	and	CC	O	O
BP	BP	NN	B-NP	O
was	be	VBD	B-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
hctz	hctz	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
Pt	Pt	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
episode	episode	NN	B-NP	O
CP	CP	NN	I-NP	O
and	and	CC	O	O
weakness	weakness	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
on	on	IN	B-PP	O
R	R	NN	B-NP	B-protein
or	or	CC	I-NP	O
L	L	NN	I-NP	B-protein
EKG	EKG	NN	I-NP	I-protein
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
resolve	resolve	VB	I-VP	O
after	after	IN	B-SBAR	O
3	3	CD	B-NP	O
nitro	nitro	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
received	receive	VBD	B-VP	O
MSO4	MSO4	NN	B-NP	O
1mg	1mg	NN	I-NP	O
and	and	CC	I-NP	O
Maalox	Maalox	NN	I-NP	O
with	with	IN	B-PP	O
complete	complete	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
and	and	CC	I-NP	O
weakness	weakness	NN	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
sx	sx	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
likely	likely	JJ	I-NP	O
poor	poor	JJ	I-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
ETT	ETT	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
Dobutamine-MIBI	Dobutamine-MIBI	NNP	B-NP	O
10/20	10/20	CD	I-NP	O
.	.	.	O	O

MIBI	MIBI	NN	B-NP	B-protein
was	be	VBD	B-VP	O
read	read	VBN	I-VP	O
as	as	IN	B-PP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

DC	DC	NNS	B-NP	B-cell_type
'd	'd	MD	B-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
ECASa	ECASa	NN	B-NP	B-protein
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
verapamil	verapamil	NN	B-NP	O
,	,	,	O	O
hctz	hctz	NN	B-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
on	on	IN	B-PP	O
Verapimil	Verapimil	NNP	B-NP	O
and	and	CC	I-NP	O
Lisinopril	Lisinopril	NNP	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Had	Had	NNP	B-NP	O
tried	try	VBD	B-VP	O
Maxzide	Maxzide	NNP	B-NP	O
in	in	IN	B-PP	O
past	past	NN	B-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
tolerate	tolerate	VB	I-VP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
``	``	``	I-NP	O
weakness	weakness	NN	I-NP	O
''	''	''	I-NP	O
sx	sx	NN	I-NP	O
,	,	,	O	O
B	B	NN	B-NP	O
blocker	blocker	NN	I-NP	O
dc	dc	NN	I-NP	O
'd	'd	NN	I-NP	O
.	.	.	O	O

Started	Started	JJ	B-NP	O
HCTZ	HCTZ	NN	I-NP	O
for	for	IN	B-PP	O
long	long	JJ	B-NP	O
term	term	NN	I-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
HTN	HTN	NN	B-NP	B-protein
.	.	.	O	O

Verapamil	Verapamil	NN	B-NP	O
480	480	CD	I-NP	O
mg	mg	NN	I-NP	O
also	also	RB	B-ADVP	O
split	split	VBD	B-VP	O
into	into	IN	B-PP	O
BID	BID	NN	B-NP	O
dosing	dosing	NN	I-NP	O
.	.	.	O	O

KDur	KDur	NN	B-NP	O
rx	rx	NN	I-NP	O
'd	'd	VBD	B-VP	O
for	for	IN	B-PP	O
hypokalemia	hypokalemia	NN	B-NP	O
.	.	.	O	O

DC	DC	NNS	B-NP	B-cell_type
'd	'd	MD	B-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
by	by	IN	B-PP	O
PMD	PMD	NN	B-NP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
bp	bp	NN	B-NP	O
check	check	NN	I-NP	O
and	and	CC	O	O
k	k	NN	B-NP	O
check	check	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Your	Your	PRP$	B-NP	O
dobutamine	dobutamine	NN	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Take	Take	VB	B-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
take	take	VB	I-VP	O
the	the	DT	B-NP	O
verapamil	verapamil	NN	I-NP	O
240	240	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
the	the	DT	B-NP	O
hctz	hctz	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
.	.	.	O	O

HCT	HCT	NN	B-NP	O
will	will	MD	B-VP	O
lower	lower	VB	I-VP	O
potassium	potassium	NN	B-NP	O
low	low	JJ	I-NP	O
,	,	,	O	O
so	so	IN	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
started	start	VBN	I-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
potassium	potassium	NN	B-NP	O
in	in	IN	B-PP	O
pill	pill	NN	B-NP	O
form	form	NN	I-NP	O
every	every	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
make	make	VBP	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Kosky	Kosky	NNP	I-NP	O
within	within	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
check	check	NN	I-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	O	O
your	your	PRP$	B-NP	O
potassium	potassium	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
may	may	MD	B-VP	O
try	try	VB	I-VP	O
maalox	maalox	NN	B-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
if	if	IN	B-SBAR	O
it	it	PRP	B-NP	O
worsens	worsen	VBZ	B-VP	O
or	or	CC	O	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
significant	significant	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
come	come	VBN	B-VP	O
to	to	TO	B-PP	O
hospital	hospital	NN	B-NP	O
or	or	CC	O	O
call	call	VB	B-VP	O
MD	MD	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
BP	BP	NN	I-NP	O
follow-up	follow-up	NN	I-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Check	Check	NNP	I-NP	O
potassium	potassium	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
hctz	hctz	NN	B-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
KOTAS	KOTAS	NNP	B-NP	O
,	,	,	O	O
FRANKLYN	FRANKLYN	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WX53	WX53	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7/29/02	7/29/02	CD	I-NP	O
@	@	SYM	B-NP	O
03	03	CD	I-NP	O
:	:	SYM	I-NP	O
13	13	CD	I-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

